More drugs being approved for rare diseases in kids (Reuters, 28 February 2012)

01 Mar 2012


A study by the FDA published in Paediatrics assesses the impact of the Orphan Drug Act, passed in 1983 to incentivise drug development in rare diseases.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story